Goldman Sachs Cuts Aetna to Sell (AET)
Aetna (NYSE: AET) was downgraded by investment analysts at Goldman Sachs (NYSE: GS) from a “neutral” rating to a “sell” rating in a note issued to investors on Wednesday. They currently have a $45.00 target price on the stock.
Aetna traded down 0.55% on Wednesday, hitting $41.85. Aetna has a 1-year low of $33.43 and a 1-year high of $51.14. The company has a market cap of $14.539 billion and a price-to-earnings ratio of 8.19.
Aetna last released its earnings data on Thursday, April 26th. The company reported $1.34 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.39 by $0.05. The company’s quarterly revenue was up 6.2% on a year-over-year basis. Analysts expect that Aetna will post $1.34 EPS next quarter.
A number of other firms have also recently commented on AET. Analysts at Zacks downgraded shares of Aetna from an “outperform” rating to a “neutral” rating in a research note to investors on Wednesday, May 2nd. They now have a $47.00 price target on the stock. Separately, analysts at Oppenheimer (NYSE: OPY) cut their price target on shares of Aetna from $48.00 to $47.00 in a research note to investors on Friday, April 27th. Finally, analysts at Wedbush raised their price target on shares of Aetna from $48.00 to $54.00 in a research note to investors on Monday, April 9th. They now have a “neutral” rating on the stock.
Aetna Inc. (Aetna) is a diversified health care benefits company, serving approximately 35.3 million people.